SEARCH

SEARCH BY CITATION

References

  • 1
    Lin KM, Lin B, Lian IY, et al. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 2001;103:17871792.
  • 2
    Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation. 2002;105:28992904.
  • 3
    Gupta S, Knowlton AA. Cytosolic Heat shock protein 60, hypoxia, and apoptosis. Circulation. 2002;106:27272733.
  • 4
    Grünenfelder J, Zünd G, Stucki V, et al. Heat shock protein upregulation lowers cytokine levels after ischemia and reperfusion. Eur Surg Res. 2001;33:383387.
  • 5
    Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol. 2007;292:H3052H3056.
  • 6
    Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res. 2009;105:11861195.
  • 7
    Lin L, Kim SC, Wang Y, et al. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol. 2007;293:H2238H2247.
  • 8
    Knowlton AA, Kapadia S, Torre-Amione G, et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998;30:811818.
  • 9
    Lewthwaite J, Owen N, Coates A, et al. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation. 2002;106:196201.
  • 10
    Halcox JP, Deanfield J, Shamaei-Tousi A, et al. Circulating human heat shock protein 60 in the blood of healty teenagers: a novel determinant of endothelial dysfunction and early vascular injury? Arterioscler Thromb Vasc Biol. 2005;25:e141e142.
  • 11
    Zhang X, He M, Cheng L, et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation. 2008;118:26872693.
  • 12
    Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000;102:1420.
  • 13
    Shamaei-Tousi A, Stephens JW, Bin R, et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J. 2006;27:15651570.
  • 14
    Shamaei-Tousi A, Steptoe A, O’Donnell K, et al. Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic, and biological factors. Cell Stress Chaperones. 2007;12:384392.
  • 15
    Niizeki T, Takeishi Y, Watanabe T, et al. Relation of serum heat shock protein 60 level to severity and prognosis in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2008;102:606610.
  • 16
    Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J. 2005;26:384416.
  • 17
    Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:23882442.
  • 18
    Yndestad A, Damas JK, Oie E, et al. Systemic inflammation in heart failure – the whys and wherefores. Heart Fail Rev. 2006;11:8392.
  • 19
    Núñez J, Núñez E, Miñana G, et al. Effectiveness of the relative lymphocyte count to predict one-year mortality in patients with acute heart failure. Am J Cardiol. 2011;107:10341039.
  • 20
    Ohashi K, Burkart V, Flohe S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164:558561.
  • 21
    Fratz S, Kobzik L, Kim YD, et al. Toll 4 (TLR-4) expression in cardiac myocites in normal and failing myocardium. J Clin Invest. 1999;104:271280.